The current pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), commonly referred to as COVID-19, brings myriad challenges to research conducted among those more susceptible to the virus. According to the United States (US) Centers for Disease Control (CDC), eight out of ten re-ported COVID-19 deaths are among people > 65 years of age and older. Nonetheless, researchers must continue the crucial work of investigating and understanding diseases that affect the elderly. The focus of this white paper is to assess the challenges associated with research within the elderly population with neurocognitive conditions. Specifically, this paper addresses the need for the standardized administration of performance measures (e.g., neurocognitive assessments) among a dementia population while ensuring the physical safety of participants. Consideration is given to the administration of performance measures and the availability and feasibility of administering these measures remotely to a population that may have difficulty using novel technologies. In implementing remote research assessments, it is suggested that researchers fol-low a GAMMA approach by: 1) establishing clear Guidance on remote visit expectations and processes; 2) establishing Appropriate exclusionary criteria in the development of the study design; 3) providing subjects Appropriate study Materials for visual processing; 4) incorporating Multiple data sources in the overall study design (e.g., caregiver input); and 5) Acknowledging that there will be study limitations as researchers use emerging technology with this patient population, and using mitigation strategies for these limitations where possible.
References
[1]
Wang, H., Li, T., Barbarino, P., Gauthier, S., Brodaty, H., Molinuevo, J.L., et al. (2020) Dementia Care during COVID-19. The Lancet, 395, 1190-1191.
https://doi.org/10.1016/S0140-6736(20)30755-8
[2]
Brown, E.E., Kumar, S., Rajji, T.K., Pollock, B.G., Mulsant, B.H. (2020) Anticipating and Mitigating the Impact of the COVID-19 Pandemic on Alzheimer’s Disease and Related Dementias. The American Journal of Geriatric Psychiatry, 28, 712-721.
https://doi.org/10.1016/j.jagp.2020.04.010
[3]
D’Adamo, H., Yoshikawa, T. and Ouslander, J.G. (2020) Coronavirus Disease 2019 in Geriatrics and Long-Term Care: The ABCDs of COVID-19. Journal of the American Geriatrics Society, 68, 912-917. https://doi.org/10.1111/jgs.16445
[4]
Lloyd-Sherlock, P., Ebrahim, S., Geffen, L. and McKee, M. (2020) Bearing the Brunt of COVID-19: Older People in Low and Middle Income Countries. British Medical Journal, 368, m1052. https://doi.org/10.1136/bmj.m1052
[5]
World Health Organization (WHO) (2019) Dementia Fact Sheet.
https://www.who.int/news-room/fact-sheets/detail/dementia
[6]
Food and Drug Administration (FDA) (2020) FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Public Health Emergency. Guidance for Industry, Investigators, and Institutional Review Boards.
https://www.fda.gov/regulatory-information/search-fda-guidance-documents/fda-guidance-conduct-clinical-trials-medical-products-during-covid-19-public-health-emergency
[7]
Clark, C.M. and Ewbank, D.C. (1996) Performance of the Dementia Severity Rating Scale: A Caregiver Questionnaire for Rating Severity in Alzheimer Disease. Alzheimer Disease and Associated Disorders, 10, 31-39.
https://doi.org/10.1097/00002093-199601010-00006
[8]
Morris, J.C. (1993) The Clinical Dementia Rating (CDR): Current Version and Scoring Rules. Neurology, 43, 2412-2414.
https://doi.org/10.1212/WNL.43.11.2412-a
[9]
Cockrell, J.R. and Folstein, M.F. (2002) Mini-Mental State Examination. In: Abou-Saleh, M.T., Katona, C.L.E., Anand, K.A., Eds., Principles and Practice of Geriatric Psychiatry, 2002 Edition, John Wiley & Sons, Ltd., Chichester, West Sussex, UK, 140-141. https://doi.org/10.1002/0470846410.ch27(ii)
[10]
Cerejeira, J., Lagarto, L. and Mukaetova-Ladinska, E.B. (2012) Behavioral and Psychological Symptoms of Dementia. Frontiers in Neurology, 3, 73.
https://doi.org/10.3389/fneur.2012.00073
[11]
Lyketsos, C.G., Lopez, O., Jones, B., Fitzpatrick, A.L., Breitner, J. and DeKosky, S. (2002) Prevalence of Neuropsychiatric Symptoms in Dementia and Mild Cognitive Impairment: Results from the Cardiovascular Health Study. The Journal of the American Medical Association, 288, 1475-1483.
https://doi.org/10.1001/jama.288.12.1475
[12]
Trier-Bieniek, A. (2012) Framing the Telephone Interview as a Participant-Centred Tool for Qualitative Research: A Methodological Discussion. Qualitative Research, 12, 630-644. https://doi.org/10.1177/1468794112439005
[13]
Kasarskis, E.J., Dempsey-Hall, L., Thompson, M.M., Luu, L.C., Mendiondo, M. and Kryscio, R. (2005) Rating the Severity of ALS by Caregivers over the Telephone Using the ALSFRS-R. Amyotroph Lateral Sclerosis, 6, 50-54.
https://doi.org/10.1080/14660820510027107
[14]
Newkirk, L.A., Kim, J.M., Thompson, J.M., Tinklenberg, J.R., Yesavage, J.A. and Taylor, J.L. (2004) Validation of a 26-Point Telephone Version of the Mini-Mental State Examination. Journal of Geriatric Psychiatry Neurology, 17, 81-87.
https://doi.org/10.1177/0891988704264534
[15]
Williams, J.B.W., Hannesdottir, K., Randolph, C., Eureyecko, E., Langbaum, J., Tariot, P., et al. (2014) Telephone Administration of the CDR—Excellent Agreement with Face-to-Face Administration.
https://www.medavante-prophase.com/wp-content/uploads/2015/07/telephone_administration_cdr1859bbc10e6e6cf4a23fff0000ac3285.pdf
[16]
Kwok, T., Wong, B., Isaac, I., Chui, K., Young, D. and Florence, H. (2013) Telephone-Delivered Psychoeducational Intervention for Hong Kong Chinese Dementia Caregivers: A Single-Blinded Randomized Controlled Trial. Clinical Interventions in Aging, 8, 1191-1197. https://doi.org/10.2147/CIA.S48264
[17]
Food and Drug Administration (FDA) (2019) Policy for Device Software Functions and Mobile Medical Applications. Guidance for Industry and Food and Drug Administration Staff.
https://www.fda.gov/regulatory-information/search-fda-guidance-documents/policy-device-software-functions-and-mobile-medical-applications
[18]
Mitsis, E.M., Jacobs, D., Luo, X., Andrews, H., Andrews, K. and Sano, M. (2010) Evaluating Cognition in an Elderly Cohort via Telephone Assessment. International Journal of Geriatric Psychiatry, 25, 531-539. https://doi.org/10.1002/gps.2373
[19]
Bunker, L., Hshieh, T.T., Wong, B., Schmitt, E.M., Travison, T., Yee, J., et al. (2017) The SAGES Telephone Neuropsychological Battery: Correlation with In-Person Measures. International Journal of Geriatric Psychiatry, 32, 991-999.
https://doi.org/10.1002/gps.4558
[20]
Schwab, N.A., DesRuisseaux, L.A., Weinberg, M.S. and Arnold, S.E. (2020) Saving Cognitive Outcome Data in Alzheimer’s Disease Clinical Trials during the COVID-19 Pandemic: Commentary on the Virtual Administration of the ADAS-Cog. Alzheimers and Dementia, 6, e12081. https://doi.org/10.1002/trc2.12081
[21]
Carotenuto, A., Rea, R., Traini, E., Ricci, G., Fasanaro, A.M. and Amenta, F. (2018) Cognitive Assessment of Patients with Alzheimer’s Disease by Telemedicine: Pilot Study. JMIR Mental Health, 5, e31. https://doi.org/10.2196/mental.8097
[22]
Montreal Cognitive Assessment (MoCA). Remote MoCA Testing.
https://www.mocatest.org/faq/
[23]
Geddes, M.R., O’Connell, M.E., Fisk, J.D., Gauthier, S., Camicioli, R., Ismail, Z., et al. (2020) Remote Cognitive and Behavioral Assessment: Report of the Alzheimer Society of Canada Task Force on Dementia Care Best Practices for COVID-19. Alzheimers and Dementia, 12, e12111. https://doi.org/10.1002/dad2.12111
[24]
DeYoung, N. and Shenal, B.V. (2019) The Reliability of the Montreal Cognitive Assessment Using Telehealth in a Rural Setting with Veterans. Journal of Telemedicine Telecare, 25, 197-203. https://doi.org/10.1177/1357633X17752030
[25]
Randolph, C., Tierney, M.C., Mohr, E. and Chase, T.N. (1998) The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): Preliminary Clinical Validity. Journal of Clinical and Experimental Neuropsychology, 20, 310-319.
https://doi.org/10.1076/jcen.20.3.310.823
[26]
Galusha-Glasscock, J.M., Horton, D.K., Weiner, M.F. and Cullum, C.M. (2016) Video Teleconference Administration of the Repeatable Battery for the Assessment of Neuropsychological Status. Archives of Clinical Neuropsychology, 31, 8-11.
https://doi.org/10.1093/arclin/acv058
[27]
Shazino (2016) Shazino Launches Neurons ResearchKit App to Help Multiple Sclerosis Patients. Press Release, Lyon, France.
http://blog.shazino.com/articles/science/neurons-multiple-sclerosis/
[28]
Apple Inc. (2020) Introducing ResearchKit. http://researchkit.org/
[29]
Compliancy Group (2020) Is Microsoft Teams HIPAA Compliant?
https://compliancy-group.com/is-microsoft-teams-hipaa-compliant/#:~:text=Yes%2C%20Microsoft%20Teams%20is%20HIPAA%20compliant
[30]
Dykes, A. (2020) The Best HIPAA Compliant Video Conferencing Tools for Telehealth. Blog, Technology Advice.
https://technologyadvice.com/blog/healthcare/hipaa-video-conferencing-tools/
[31]
Vaportzis, E., Clausen, M.G. and Gow, A.J. (2017) Older Adults Perceptions of Technology and Barriers to Interacting with Tablet Computers: A Focus Group Study. Frontiers in Psychology, 8, 1687. https://doi.org/10.3389/fpsyg.2017.01687
[32]
Pew Research Center (2017) Barriers to Adoption and Attitudes towards Technology.
https://www.pewresearch.org/internet/2017/05/17/barriers-to-adoption-and-attitudes-towards-technology/
[33]
Abdelrahman, N.G., Haque, R., Polverento, M.E., Wendling, A., Goetz, C.M. and Arnetz, B.B. (2021) Brain Health: Attitudes towards Technology Adoption in Older Adults. Healthcare, 9, 23. https://doi.org/10.3390/healthcare9010023
[34]
Betts, L.R., Hill, R. and Gardner, S.E. (2019) There’s Not Enough Knowledge Out There: Examining Older Adults’ Perceptions of Digital Technology Use and Digital Inclusion Classes. Journal of Applied Gerontology, 38, 1147-1166.
https://doi.org/10.1177/0733464817737621
[35]
Health Measures. NIH Toolbox®.
https://www.healthmeasures.net/explore-measurement-systems/nih-toolbox
[36]
Schmitt, F.A., Saxton, J., Ferris, S.H., Mackell, J. and Sun, Y. (2013) Evaluation of an 8-Item Severe Impairment Battery (SIB-8) vs. the Full SIB in Moderate to Severe Alzheimer’s Disease Patients Participating in a Donepezil Study. The International Journal of Clinical Practice, 67, 1050-1056. https://doi.org/10.1111/ijcp.12188
